Anti-Fibrotic Effect of Ajulemic Acid in Bleomycin-Induced Lung Fibrosis

被引：0
|
作者：
Lucattelli, Monica [1 ]
Fineschi, Silvia [1 ]
Selvi, Enrico [2 ]
Gonzales, Estrella Garcia [2 ]
Balistrieri, Epifania [2 ]
Lorenzini, Sauro [2 ]
Galeazzi, Mauro [2 ]
Distler, Jorg [3 ]
Lungarella, Giuseppe [1 ]
机构：
[1] Univ Siena, Life Sci, I-53100 Siena, Italy
[2] Univ Siena, Med & Immunol Sci, I-53100 Siena, Italy
[3] Univ Erlangen Nurnberg, Internal Med, Erlangen, Germany
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LB744
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Therapeutic Anti-Fibrotic Effect of Nintedanib in a Rat Model of Lung Fibrosis Induced by a Double Bleomycin Intratracheal Administration
    Pitozzi, V.
    Caruso, P.
    Pontis, S.
    Pittelli, M.
    Bonatti, M.
    Frati, C.
    Madeddu, D.
    Quaini, F.
    Lagrasta, C.
    Villetti, G.
    Civelli, M.
    Trevisani, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Anti-fibrotic effects of different sources ofMSCin bleomycin-induced lung fibrosis inC57BL6male mice
    Periera-Simon, Simone
    Xia, Xiaomei
    Catanuto, Paola
    Coronado, Ramon
    Kurtzberg, Joanne
    Bellio, Michael
    Lee, Yee-Shuan
    Khan, Aisha
    Smith, Robin
    Elliot, Sharon J.
    Glassberg, Marilyn K.
    RESPIROLOGY, 2021, 26 (02) : 161 - 170
  • [23] Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice
    Cai, Yan
    Kimura, Shioko
    PLOS ONE, 2015, 10 (11):
  • [24] PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone
    Gagnon, Lyne
    Tremblay, Mikael
    Sarra-Bournet, Francois
    Gervais, Liette
    Abbott, Shaun
    Duceppe, Jean-Simon
    Zacharie, Boulos
    Penney, Christopher
    Laurin, Pierre
    Grouix, Brigitte
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [25] The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats
    Gad, E. S.
    Salama, A. A. A.
    El-Shafie, M. F.
    Arafa, H. M. M.
    Abdelsalam, R. M.
    Khattab, M.
    INFLAMMATION, 2020, 43 (01) : 123 - 134
  • [26] THE ANTI-FIBROTIC EFFECT OF MYCOPHENOLATE MOFETIL OF THROUGH INHIBITING TGE-BETA-INDUCED ERK PATHWAY IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    Choe, J. -V.
    Jung, H. -Y.
    Park, S. -H.
    Kim, S. -K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S109 - S109
  • [27] Quantification of Fibrotic and Inflammatory Changes in a Bleomycin-induced Lung Fibrosis Model
    Garrido, Rosario
    Tyagi, Gaurav
    Adames, Violet
    Wolujczyk, Alex
    Peng, Ruoqi
    Woods, John
    Stevenson, Christopher
    Odin, Marielle
    FASEB JOURNAL, 2011, 25
  • [28] Effects of a Leukotriene B4 Receptor Antagonist, an Anti-Inflammatory and Anti-Fibrotic Agent, on Bleomycin-Induced Pulmonary Fibrosis
    Izumo, T.
    Kondo, M.
    Nagara, N.
    Iritani, E.
    Tamaoki, J.
    Nagai, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [29] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin- induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [30] Anti-fibrotic effect of meloxicam in a murine lung fibrosis model
    Arafa, Hossam M. M.
    Abdel-Wahab, Mohamed H.
    El-Shafeey, Mohamed F.
    Badary, Osama A.
    Hamada, Farid M. A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 564 (1-3) : 181 - 189
12345